The triple combination treatment increased circulating IFN-γ levels and enhanced the recruitment of CD4 + T cells, CD8 + T cells, and M1 macrophages within the tumor microenvironment, potentially contributing to an improved antitumor immune response and tumor growth inhibition. This evidence concerns the gene CD8A and neoplasm.